COMMUNIQUÉS West-GlobeNewswire

Picard Medical Announces Leadership Transition
24/06/2026
Chairman, Richard Fang Appointed Interim Chief Executive Officer TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of [...]
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
24/06/2026
Greater than 60% increase in laboratory space will strengthen R&D capabilities, facilitate acceleration toward clinical development, and increase ability to tap into Heidelberg’s world-class medical oncology [...]
SRX Global Announces Share Consolidation
24/06/2026
NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-conviction operating [...]
Respiree Appoints Patty Riskind as Chair of the Board of Directors
24/06/2026
HOUSTON and SINGAPORE, June 24, 2026 (GLOBE NEWSWIRE) -- Respiree, a leading AI-driven healthcare company advancing predictive cardiorespiratory monitoring and proactive care, announced today the appointment of Patty [...]
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
24/06/2026
Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial in HIT, a life [...]
Mammogen Appoints Physician Executive and Breast Imaging Leader, Dr. Elise Berman, as Chief Medical Officer
24/06/2026
Berman Joins Mammogen to Support Next Phase of Growth Following $30 Million Series A Financing to Advance RNA-Based Breast Cancer Detection Platform NEWPORT BEACH, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Mammogen , a [...]
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
24/06/2026
Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expression SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Calidi [...]
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
24/06/2026
WALTHAM, Mass., June 24, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies [...]
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
24/06/2026
BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all proposals presented [...]
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
24/06/2026
Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience Dr. Vinod Thourani appointed Clinical [...]
BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026
24/06/2026
NETANYA, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that its majority-owned subsidiary company DFSL Ltd. (“DFSL”) will showcase next-generation [...]
Bionano Announces Hiring of Chief Scientific Officer
24/06/2026
SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D. , as its Chief Scientific Officer (CSO) , [...]
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
24/06/2026
Exclusive license and commercialization agreement includes a significant profit share of gross margin from product sales in addition to an upfront license payment to LENZ SAN DIEGO and MELBOURNE, Australia, June 24, [...]
BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints
24/06/2026
Jersey on. Crew ready. If England, Scotland or the U.S. reaches the final, fans can head straight to participating BrewDog pubs 1 and Tilray-owned brewpubs 2 across the U.S. to claim up to two free pints before the £1 [...]
Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress
24/06/2026
Expands Response Biomedical beyond acute care into chronic disease and wellness testing Introduces a next-generation platform for metabolic and inflammatory biomarker testing Combines speed, portability, and workflow [...]
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
24/06/2026
Financing led by Frazier Life Sciences with participation from new investors EQT Life Sciences, Forbion, Monograph , Wellington Management and founding investor LifeArc Ventures Proceeds support clinical development of [...]
FEATOL Introduces Anti-Fatigue Mat Designed to Improve Comfort During Long Hours of Standing
24/06/2026
NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- FEATOL, a brand specializing in ergonomic support and protective products, has introduced its Anti Fatigue Mat , designed to help reduce the discomfort and fatigue commonly [...]
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24/06/2026
ZUG, Switzerland , June 23, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today [...]
uniQure Announces Pricing of Upsized $225 Million Public Offering
24/06/2026
LEXINGTON, Mass. and AMSTERDAM, June 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]

Pages